HIV-1-associated Dementia (HAD) is a significant consequence of HIV infection. Although multiple inflammatory factors contribute to this chronic, progressive dementia, excitotoxic damage appears to be an underlying mechanism in the neurodegenerative process. Excitotoxicity is a cumulative effect of multiple processes occurring in the CNS during HAD. The overstimulation of glutamate receptors, an increased vulnerability of neurons, and disrupted astrocyte support each potentiate excitotoxic damage to neurons. Recent evidence suggests that poorly controlled generation of glutamate by phosphate-activated glutaminase may contribute to the neurotoxic state typical of HAD as well as other neurodegenerative disorders. Glutaminase converts glutamine, a widely available substrate throughout the CNS to glutamate. Inflammatory conditions may precipitate unregulated activity of glutaminase, a potentially important mechanism in HAD pathogenesis.
Introduction
Human immunodeficiency virus has had a profound impact on global health. With worldwide infections near 40 million and approximately 20 million attributable deaths, HIV continues to be a growing problem [1] . HIV notoriously targets the immune system, progressively degrading the host defense system until opportunistic infection or systemic failure results in a fatal outcome. In addition to the attack on immune function, HIV is also linked to a syndrome of cognitive and motor dysfunction termed HIV-associated dementia (HAD) [2] . This frank dementia is a result of neuronal cell dysfunction and death in the CNS, yet HIV rarely infects neurons. While much research has investigated this viral induced dementia, a clear mechanism for neuronal damage has yet to be established.
HAD is the clinical consequence of a persistent inflammatory process in the CNS causing neurotoxicity. HIV-1 infection of the brain occurs in the early stages of infection [3] , with evidence supporting CNS invasion during the primary viremia that accompanies seroconversion [4] . Peripherally infected monocytes cross the blood-brain barrier, seeding the brain with virus [5] [6] [7] . HAD is a diagnosis of exclusion and typically only manifests during the later stages of disease. The dementia includes a spectrum of neurological impairments including forgetfulness, apathy, hallucinations, delirium, coma, and ultimately death [2, 8] . The dementia once affected 20-30% of those with advanced HIV, but this number has decreased since the advent of anti-retroviral therapy (ART) in developed countries to around 10% [9, 10] . However, ART cannot completely protect from or reverse HAD [9] . A more subtle collection 
